Yamamoto Y - Search Results

1

High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer.

Miyasato Y, Shiota T, Ohnishi K, Pan C, Yano H, Horlad H, Yamamoto Y, Yamamoto-Ibusuki M, Iwase H, Takeya M, Komohara Y. Miyasato Y, et al. Among authors: yamamoto y, yamamoto ibusuki m. Cancer Sci. 2017 Aug;108(8):1693-1700. doi: 10.1111/cas.13287. Epub 2017 Jul 3. Cancer Sci. 2017. PMID: 28574667 Free PMC article.

2

[Experience of high-dose toremifene treatment for postmenopausal women with metastatic breast cancer].

Yamamoto Y, Kawazoe T, Iwase H. Yamamoto Y, et al. Gan To Kagaku Ryoho. 2005 Oct;32(10):1415-9. Gan To Kagaku Ryoho. 2005. PMID: 16227740 Japanese.

3

[Two cases of stage IV breast cancer with severe hypercalcemia].

Ohsako T, Yamamoto Y, Kawazoe T, Inoue K, Nagamoto N, Yoshida Y, Nakahara O, Sakamoto N, Iwase H. Ohsako T, et al. Among authors: yamamoto y. Gan To Kagaku Ryoho. 2006 Feb;33(2):223-6. Gan To Kagaku Ryoho. 2006. PMID: 16484860 Japanese.

4

A case report of paraneoplastic neurological syndrome associated with occult breast cancer.

Kawasoe T, Yamamoto Y, Okumura Y, Iwase H. Kawasoe T, et al. Among authors: yamamoto y. Breast Cancer. 2006;13(2):202-4. doi: 10.2325/jbcs.13.202. Breast Cancer. 2006. PMID: 16755118 Free article.

5

Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells.

Kurebayashi J, Nukatsuka M, Nagase H, Nomura T, Hirono M, Yamamoto Y, Sugimoto Y, Oka T, Sonoo H. Kurebayashi J, et al. Among authors: yamamoto y. Cancer Chemother Pharmacol. 2007 Mar;59(4):515-25. doi: 10.1007/s00280-006-0293-7. Epub 2006 Aug 10. Cancer Chemother Pharmacol. 2007. PMID: 16900372

6

Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.

Zhang Z, Yamashita H, Toyama T, Yamamoto Y, Kawasoe T, Iwase H. Zhang Z, et al. Among authors: yamamoto y. Clin Cancer Res. 2006 Nov 1;12(21):6410-4. doi: 10.1158/1078-0432.CCR-06-1347. Clin Cancer Res. 2006. PMID: 17085653

7

[Prediction for efficacy of endocrine therapy for breast cancers using gene profiling].

Iwase H, Yamamoto Y. Iwase H, et al. Among authors: yamamoto y. Nihon Rinsho. 2007 Jun 28;65 Suppl 6:549-54. Nihon Rinsho. 2007. PMID: 17682209 Review. Japanese. No abstract available.

8

Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer.

Yamamoto Y, Ibusuki M, Okumura Y, Kawasoe T, Kai K, Iyama K, Iwase H. Yamamoto Y, et al. Breast Cancer Res Treat. 2008 Aug;110(3):465-75. doi: 10.1007/s10549-007-9742-1. Epub 2007 Sep 6. Breast Cancer Res Treat. 2008. PMID: 17805961

9

[Treatment guideline for breast cancer and SERM-treatment].

Iwase H, Yamamoto Y, Kawasoe T. Iwase H, et al. Among authors: yamamoto y. Nihon Rinsho. 2007 Nov 28;65 Suppl 9:636-40. Nihon Rinsho. 2007. PMID: 18159717 Review. Japanese. No abstract available.

10

Pathological lymph node involvement at surgery is a significant predictive factor of recurrence in locally advanced breast cancer treated with concomitant epirubicin-docetaxel neoadjuvant chemotherapy: a cohort study.

Kai K, Arima N, Miyayama H, Yamamoto Y, Iwase H, Nishimura R. Kai K, et al. Among authors: yamamoto y. Breast Cancer. 2009;16(1):42-8. doi: 10.1007/s12282-008-0055-y. Epub 2008 May 27. Breast Cancer. 2009. PMID: 18504642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,308 results

Search Page

Filters